Kaya Ltd Posts ₹96 Cr Loss in FY26, Raises ₹75 Cr Capital

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Kaya Ltd Posts ₹96 Cr Loss in FY26, Raises ₹75 Cr Capital

Kaya Limited reported a consolidated net loss of ₹96.17 crore for FY26, a sharp increase from the previous year. The company raised ₹75 crore via preferential issue to fund expansion.

Kaya Limited Reports Significant FY26 Net Loss Amidst Capital Infusion

Kaya Ltd posted a consolidated net loss of ₹96.17 crore for the fiscal year 2026, while its revenue from operations saw a modest increase of 2.3% to ₹222.48 crore.

Reader Takeaway: Mounting losses despite revenue growth and capital infusion signal significant operational challenges.

What just happened

Kaya Limited announced its financial results for the fiscal year ending March 31, 2026. The company reported a consolidated net loss of ₹96.17 crore. Standalone revenue from operations grew by 2.3% to ₹222.48 crore from ₹217.42 crore in FY25. However, standalone net losses widened to ₹96.13 crore compared to ₹26.51 crore in the previous year.

Why this matters

The significant widening of net losses is a major concern for investors, indicating that operational expenses are outpacing revenue growth. The company's reliance on promoter support for its going concern status highlights financial vulnerability. The capital infusion of ₹75 crore provides much-needed liquidity but its effectiveness hinges on successful expansion and turnaround.

The backstory

In FY25, Kaya Limited benefited from discontinued operations, which masked underlying profitability issues. The current results show a return to significant losses on a standalone basis, suggesting ongoing challenges in clinic operations and cost management. The company has been pursuing expansion and modernization initiatives.

What changes now

The ₹75 crore raised through a preferential issue to Axana Estates LLP will be used for opening new clinics, relocations, and investing in new machinery. This fresh capital is intended to support the company's growth strategy and improve operational efficiency.

Risks to watch

  • Going Concern: The company's current liabilities exceed its current assets by ₹100.14 crore as of March 31, 2026. Management's reliance on promoter group support for continued operations is a key risk.
  • Income Tax Survey: An ongoing survey action by the Income Tax Department at the company's head office and a clinic requires careful monitoring.
  • Tax Disputes: Outstanding disputed tax matters, though relatively small at ₹1.66 crore, add to the list of financial uncertainties.

Peer comparison

While specific peer financial data isn't provided in the filing, the beauty and wellness sector in India is competitive. Companies in this space typically face pressure on margins due to high operational costs and customer acquisition expenses. Kaya's increased losses suggest it may be underperforming relative to its peers' ability to manage costs or generate consistent profits.

Context metrics (time-bound)

  • FY26 Consolidated Revenue: ₹222.48 crore
  • FY26 Consolidated Net Loss: ₹96.17 crore
  • Capital Infusion (Preferential Issue): ₹75 crore
  • Preferential Issue Date: August 12, 2025
  • AGM Date: August 7, 2026

What to track next

Investors will be looking for signs of improvement in profitability in the upcoming quarters, the successful deployment of the new capital for expansion, and the resolution of the income tax survey and other tax disputes. The company's ability to sustain operations as a going concern will be a critical factor to monitor.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.